Aristotle Capital Boston LLC Decreases Position in Pediatrix Medical Group, Inc. (NYSE:MD)

Aristotle Capital Boston LLC trimmed its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 8.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 657,040 shares of the company's stock after selling 62,904 shares during the period. Aristotle Capital Boston LLC owned approximately 0.77% of Pediatrix Medical Group worth $8,620,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in MD. ArrowMark Colorado Holdings LLC increased its position in shares of Pediatrix Medical Group by 1.9% during the 4th quarter. ArrowMark Colorado Holdings LLC now owns 802,898 shares of the company's stock valued at $10,534,000 after purchasing an additional 15,249 shares during the last quarter. Northern Trust Corp increased its holdings in Pediatrix Medical Group by 18.0% during the fourth quarter. Northern Trust Corp now owns 966,347 shares of the company's stock valued at $12,678,000 after buying an additional 147,522 shares during the last quarter. HBK Investments L P purchased a new position in shares of Pediatrix Medical Group during the 4th quarter worth $273,000. Oberweis Asset Management Inc. purchased a new position in shares of Pediatrix Medical Group during the 4th quarter worth $6,122,000. Finally, Hancock Whitney Corp purchased a new stake in shares of Pediatrix Medical Group in the 4th quarter worth $160,000. Institutional investors own 97.71% of the company's stock.

Pediatrix Medical Group Price Performance

MD traded up $1.56 during trading on Tuesday, hitting $14.51. 1,381,420 shares of the company traded hands, compared to its average volume of 847,675. The company has a market cap of $1.25 billion, a PE ratio of -12.09, a P/E/G ratio of 1.74 and a beta of 1.26. Pediatrix Medical Group, Inc. has a 1 year low of $6.62 and a 1 year high of $17.67. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The stock's 50-day simple moving average is $13.70 and its two-hundred day simple moving average is $14.00.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its earnings results on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The firm had revenue of $502.36 million for the quarter, compared to analysts' expectations of $486.22 million. As a group, sell-side analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have recently commented on MD shares. StockNews.com raised Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research note on Wednesday, January 22nd. Truist Financial lowered their price target on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a report on Friday, April 11th. Finally, UBS Group increased their price objective on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a "neutral" rating in a research note on Friday, February 21st. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $16.75.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.